Lv42
788 积分 2023-04-24 加入
Long-term Therapy Outcomes of CD19/22 CAR T Cell Alone or with Autologous Stem Cell Transplantation for Relapsed/Refractory DLBCL
4小时前
已完结
Addressing Unmet Needs in Atopic Dermatitis: Evaluating Disease-Modifying Capabilities of Current and Emerging Therapies
3天前
已完结
Chronic Spontaneous Urticaria and Comorbidities
5天前
已完结
Efficacy and safety of abrocitinib versus dupilumab in adults with moderate-to-severe atopic dermatitis: a randomised, double-blind, multicentre phase 3 trial
5天前
已完结
New treatments for atopic dermatitis targeting beyond IL-4/IL-13 cytokines
6天前
已完结
Trastuzumab Deruxtecan after Endocrine Therapy in Metastatic Breast Cancer
15天前
已完结
Inavolisib-Based Therapy in PIK3CA -Mutated Advanced Breast Cancer
15天前
已完结
Real‐world efficacy and safety of dupilumab in Chinese patients with atopic dermatitis: a single‐centre, prospective, open‐label study
20天前
已完结
Evolution of dupilumab‐associated conjunctivitis in patients with atopic dermatitis after switching dupilumab to tralokinumab or Janus kinase inhibitors (RESO‐ADOC study)
27天前
已完结
皖公网安备34019202002308
